You are here

International Agency for Research on Cancer (IARC)

The International Agency for Research on Cancer (IARC) is part of the World Health Organization. IARC's mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer prevention and control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships.

IARC promotes international collaboration in cancer research. The Agency is inter-disciplinary, bringing together skills in epidemiology, laboratory sciences and biostatistics to identify the causes of cancer so that preventive measures may be adopted and the burden of disease and associated suffering reduced. A significant feature of the IARC is its expertise in coordinating research across countries and organizations; its independent role as an international organization facilitates this activity.

Role in the project

IARC will lead WP5 (Metabolomics, within SP3 - Internal exposome: omic approaches for developing novel biomarkers of exposure), WP10 (Impact and Dissemination), and will participate in WP7 (Other omics).

Key persons to be involved

Name  Expertise Role in the project
Professor Chris P. Wild Cancer Scientist WP10
Dr Augustin Scalbert Analytical chemistry, food and nutrition
research, application of metabolomics
for biomarker discovery
 
WP5, WP6, WP10
Dr Zdenko Herceg Molecular biology, epigenetics and
cancer research
 
 WP3 Leader
Dr  Sabina Rinaldi Hormone analysis and cancer
 
WP5, WP6
Dr Hector Hernandez Vargas Epigenetics
 
WP7
Mr David Achaintre Metabolomics
 
WP5
Mr Cyrille Cuenin Epigenetics
 
WP7
Ms Véronique Terrasse Communication Specialist
 
WP10